| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/16/2023 | Taysha Gene Therapies, Inc. | | Purchase | Common Stock | 388.9k | $0.90 | $350k | See footnote | 08/16/2023 |
| 08/16/2023 | Taysha Gene Therapies, Inc. | | Purchase | Common Stock | 388.9k | $0.90 | $350k | | 08/16/2023 |
| 08/16/2023 | Taysha Gene Therapies, Inc. | | Gift | Common Stock | 50k | $0.00 | $0 | | 08/16/2023 |
| 06/06/2023 | Acumen Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 25k | $5.20 | $130k | | 06/06/2023 |
| 07/05/2022 | Verrica Pharmaceuticals Inc. | VRCA | Purchase | Common Stock | 238.1k | $2.10 | $500k | | 07/05/2022 |
| 06/15/2022 | Acumen Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 25k | $3.59 | $89.8k | | 06/15/2022 |
| 07/06/2021 | Acumen Pharmaceuticals, Inc. | | Conversion | Common Stock | 130.2k | $0.00 | $0 | | 07/06/2021 |
| 07/06/2021 | Acumen Pharmaceuticals, Inc. | | Conversion | Common Stock | 131.6k | $0.00 | $0 | See footnote | 07/06/2021 |
| 07/06/2021 | Acumen Pharmaceuticals, Inc. | | Purchase | Common Stock | 35k | $16.00 | $560k | | 07/06/2021 |
| 07/06/2021 | Acumen Pharmaceuticals, Inc. | | Conversion | Series A-1 Preferred | 130.2k | $0.00 | $0 | | 07/06/2021 |
| 07/06/2021 | Acumen Pharmaceuticals, Inc. | | Conversion | Series B Preferred | 131.6k | $0.00 | $0 | See footnote | 07/06/2021 |
| 06/30/2021 | Acumen Pharmaceuticals, Inc. | | Grant | Stock Option (Right to Buy) | 34k | $16.00 | $544k | | 06/30/2021 |
| 08/14/2020 | Verrica Pharmaceuticals Inc. | VRCA | Purchase | Common Stock | 15.7k | $6.38 | $100.2k | | 08/13/2020 |
| 08/13/2020 | Verrica Pharmaceuticals Inc. | VRCA | Purchase | Common Stock | 15.6k | $6.45 | $100.3k | | 08/13/2020 |
| 11/12/2019 | Dova Pharmaceuticals, Inc. | DOVA | Other | Common Stock | 635.7k | $27.50 | $17.5M | | 11/12/2019 |
| 01/07/2019 | Verrica Pharmaceuticals Inc. | VRCA | Purchase | Common Stock | 1.2k | $10.94 | $13.1k | | 01/07/2019 |
| 01/07/2019 | Verrica Pharmaceuticals Inc. | VRCA | Purchase | Common Stock | 8k | $10.38 | $83.3k | | 01/07/2019 |
| 12/20/2018 | Dova Pharmaceuticals, Inc. | DOVA | Purchase | Common Stock | 31k | $6.26 | $194.1k | | 12/20/2018 |
| 06/19/2018 | Verrica Pharmaceuticals Inc. | VRCA | Conversion | Series A Convertible Preferred Stock | 394.3k | $0.00 | $0 | | 06/19/2018 |
| 06/19/2018 | Verrica Pharmaceuticals Inc. | VRCA | Conversion | Common Stock | 394.3k | $0.00 | $0 | | 06/19/2018 |